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Objective: To conﬁrm altered perfusion within tibial bone marrow lesions (BMLs) and improve our
understanding on the relationship between BMLs and pain in knee osteoarthritis (OA).
Methods: Participants with moderate to severe knee OA were recruited and pain was assessed using the
pain subscale of the Western Ontario and McMaster Universities Arthritis Index (WOMAC). Subchondral
tibial BMLs were identiﬁed and graded on magnetic resonance imaging (MRI) proton density-weighted
(PDW) fat suppressed images. A pharmacokinetic model was used to analyze perfusion parameters on
dynamic contrast enhanced (DCE) MRI which represent transfer rates in and out of the BMLs. The
relation between perfusion and pain was evaluated using multivariable linear regression after adjust-
ment for BML grade, age, gender and body mass index (BMI).
Results: There were 37 participants (mean age 64.9 years, range 46e86) with radiographic Kellgren and
Lawrence grades of 3 and 4 in the study knee; 75.6% had BMLs that were classiﬁed grades 1 and 2. The
mean WOMAC pain score was 10.3 (0e20 scale). There was a signiﬁcant correlation between BML Kel
(rate of contrast elimination) and BML grade (P ¼ 0.001 univariate, P ¼ 0.002 multivariate analyses),
although we did not demonstrate any signiﬁcant multivariate association between BML perfusion and
pain. We also found an inverse relationship between pain at sleep and BML grade (P < 0.05).
Conclusions: The absence of any signiﬁcant association between bone perfusion and pain implies that the
relationship of tibial BMLs to pain in OA is still incompletely understood. BMLs are just one component of
the whole knee joint and are formed from various causes, all of which interact and collectively contribute
to the genesis of pain in OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is themost common joint disease inmodern,
aging societies and causes substantial physical and psychosocial
disability1. The risk for disability (deﬁned as needing help walking
or climbing stairs) attributable to knee OA is as great as that
attributable to cardiovascular disease and greater than that due to
any other medical condition in elderly persons1. OA occurs when
the dynamic equilibrium between the breakdown and repair of
joint tissues is overwhelmed by a combination of genetic, metabolic
and hormonal factors interacting with local biomechanical forces2.
This progressive joint failure may cause pain, physical disability,
and psychological distress1, although many persons with structural
and radiological changes consistent with OA are asymptomatic3.: D.J. Hunter, Rheumatology
Clinical School, University of
-7379; Fax: 61-2-9906-1859.
Hunter).
s Research Society International. PThe reasons why there is this disconnect between disease severity
and the level of reported pain and disability is unknown. In
advanced OA, pain can be present with progressively less activity
eventually occurring at rest or nocturnally.
The source of pain in OA is best framed in a biopsychosocial
framework (posits that biological, psychological and social factors
all play a signiﬁcant role in pain in OA)4. The structural determi-
nants (part of the biological determinants) of pain and mechanical
dysfunction in OA are also not well understood, but are believed to
involve multiple interactive pathways. One important source of
nociceptive input is the subchondral bone. During the initiation and
progression of OA, subchondral bone is the site of numerous
dynamic morphological transformations due to an altered osteo-
blast metabolism, which is part of the pathological process5. These
in situ structural changes in subchondral bone can be readily
observed using imaging techniques such as MRI during the course
of OA.
Onmagnetic resonance imaging (MRI), subchondral bonemarrow
signal alterations are characterized by ill-deﬁned subchondral areasublished by Elsevier Ltd. All rights reserved.
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(PDW) fat suppressed (FS) fast spin echo (FSE) or short tau inver-
sion recovery (STIR) images5. These bone marrow lesions (BMLs)
play an integral if not pivotal role in the symptoms that emanate
from knee OA and its structural progression6. More recently their
relation to pain severity was also demonstrated. These edema-like
lesions gradually increase in size over time and their presence in
subchondral bone marrow has been associated with increased bone
turnover indices as well as structural deterioration in knee OA7,8.
After intravenous administration of contrast agents, enhancement of
these signal alterations is evident, indicating hypervascularity and
repair activity9,10. Contrast kinetics of small molecular agents in
bone result from a combination of both perfusion and permeability
effects11. These combined effects shall be referred to as properties of
bone perfusion in this study.
Another bone-related cause of pain is bone angina due to
decreased blood ﬂow and elevated intraosseous pressure12. It has
been suggested that OA has early vascular components that change
underlying bone perfusion in the affected bone13. The pathophys-
iology of this change remains unclear, although phlebographic
studies in OA indicate impaired vascular clearance from bone and
raised intraosseous pressure in the bone marrow near the painful
joint12,14e16. These prior studies demonstrated elevated intra-
osseous pressures in hip and knee OAwhilst patients without OA or
pain had normal intraosseous pressures. Furthermore, osteotomy
of the proximal femur reduced both intraosseous pressure and the
subsequent pain in patients with hip OA12,14e16. These studies
collectively suggest that BMLs may lead to changes in ﬂuid
dynamics which result in the intraosseous hypertension that is
associated with bone pain in OA.
Interestingly, limited analysis of BMLs appear to correspond to
thrombi, diffuse ﬁbrinoid necrosis, myxedematous degeneration
and cellular inﬁltrate of the bone marrow e all indicative of
infarction-like pathology17,18. These ﬁndings strengthen the
association that subchondral bone changes contribute to the
pain, bone remodeling and bone necrosis that occurs in patients
with OA.
Although the presence of BMLs is strongly associated with the
progression and pain in OA, the particular bone pathology most
responsible for pain remains elusive. Identifying this would be
a major advance in delineating appropriate therapeutic targets.
The aims of this study are to conﬁrm our preliminary data
demonstrating altered perfusion within tibial BMLs19 and to
improve our mechanistic understanding of why tibial BMLs are
related to pain by examining the relationship between tibial BML
size and perfusion as well the association between tibial BML
perfusion to pain severity and pain at rest or sleep.
Methods
Study sample
We conducted a pilot study to examine the objectives. We
recruited 37 participants (age range: 46e86 years, body mass
index (BMI) range 21.4e35.2) with knee OA who were on
a waiting list for total knee replacement (TKR). Participants had
skyline and bilateral standing anteroposterior (AP) radiographs
during the screening phase. The radiographic Kellgren and
Lawrence grade in the knees of participants ranged from grades
3 to 4. Exclusion criteria included pregnant women, those who
were having a revision knee replacement instead of a primary
knee replacement, a contraindication for MRI scans and those
with an allergy to the contrast agent gadolinium. Any patient
with an underlying pathophysiology that could possible
inﬂuence pain beyond the impact of OA alone (such asrheumatoid arthritis (RA), infection, gout, or neuropathic
disorders) was also excluded. The institutional review board of
New England Baptist Hospital approved the study. Informed
consent was obtained from all study participants.
Assessment of symptoms
Painwas assessed using the pain subscale of the Likert version of
the Western Ontario and McMaster Universities Arthritis Index
(WOMAC)20. This disease-speciﬁc measure is reliable, valid and
responsive and consists of ﬁve pain items, 17 function items and
two stiffness items using a 5-point scale to score each item, where
higher scores indicate worse symptoms. Five categories of pain
(walking on ﬂat surface, going up or down stairs, pain present at
night while in bed, sitting or lying or standing upright) were
assessed separately with a 5-point scale from 0 (no pain) to 4 (most
severe pain). Each score was then summed to create a total pain
score (range 0e20). Pain scores at night while sleeping range from
0 (none) to 3 (severe).
MRI acquisition
Subjects had an MRI performed of their study knee prior to TKR
(within 2 weeks of their surgery date) on a 1.5 T scanner with
a dedicated 8-channel extremity coil (1.5 T Twin Speed Excite
scanner (GE Healthcare,Waukesha,WI)). TheMR exam consisted of
an axial and sagittal PDW FS series and a high-resolution coronal
T1-Weighted 3D spoiled gradient echo (SPGR) acquisition with
water excitation. The following imaging sequences were used for
BML localization on each patient: both axial and sagittal PDW FS
with repetition time (TR)/echo time (TE) of approximately 3550 ms
and 20e30 ms respectively. Acquisition parameters of 3 mm slices,
no skip/gap, 320  224 matrix, ﬂip angle 90, receiver bandwidth
(RCV BW) 31.25, 15 cm ﬁeld of view (FOV) (for distal femur and
proximal tibia) for a total acquisition time of 4.5 min.
Gadolinium-DTPA (Gd-DTPA) was injected at a peripheral intra-
venous site at a standard concentration of 0.1 mmol per kg using
a power injector followed by a saline ﬂush. Dynamic contrast
enhanced (DCE)MRIwas performed using a sagittal 3D T1-weighted
fast spoiled gradient echo (FSPGR) sequencewith 20 sagittal slices of
3 mm thickness over 7 minwith a 7.5 s time resolution. During data
acquisition, the TR was 6.6 and TE was 1.7 with a 12 ﬂip angle, RCV
BW 50, a 12 cm FOV and a 256  128 matrix.
MRI analysis
Subchondral BMLs were initially identiﬁed on both axial and
sagittal PDW FS images. As the focus of this analysis is on tibial
BMLs the largest tibial BML was scored. This region was utilized for
DCE MRI perfusion analysis and deﬁned as discrete areas of
increased signal adjacent to subcortical bone. Each BMLwas graded
from 0 to 3 on the basis of lesion size according to the Boston Leeds
Osteoarthritis Knee Score (BLOKS) scoring system21. One region of
interest (ROI) in each knee was deﬁned that circumscribed the
outline of the BML. This ROI was deﬁned on multiple slices and
averaged to create a single time intensity curve representative of
the primary BML lesion in each subject. The grading for size of BML
for BLOKS includes the cystic component. Similarly the ROI for BML
incorporated the cystic component. Each patient underwent a DCE
MRI scan while dynamic perfusion data was extracted using
mathematical modeling based on the Brix two-compartment
pharmacokinetic model22,23. Analysis was performed using in-
house software [JD] written in IDL 7.0 [ITT Visual, Boulder CO].
Brieﬂy, the Brix two-compartment model is capable of producing
perfusion parameters such as transfer rates into and out of a ROI.
Table I
Baseline demographics of study population (n ¼ 37)
M:F ratio 21:16
Age, mean (years) 64.9 (range 46e86)
BMI, mean (kg/m2) 28.9 (range 21.4e35.2)
Pain score at night while sleeping (n, %)
1 15 (40.5)
2 16 (43.3)
3 6 (16.2)
WOMAC pain, 0e20 scale 10.2 (range 3e15)
BML grade (n, %)
1 14 (37.8)
2 14 (37.8)
3 9 (24.4)
Fig. 1. Chart of BML Kel with BML grade. Kel decreases with increasing BML size
showing delayed outﬂow postulated to represent venous obstruction.
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are:
i. Slope (%/min) e initial uptake of Gd into the region found by
ﬁnding the fastest uptake in the ﬁrst few minutes after
injection
ii. A (unitless) e corresponds to the size of the extravascular
extracellular space (EES) or area the Gd can leak into outside
the plasma and not internal to the cells
iii. Kep (1/min) e efﬂux rate constant from EES to plasma which
provides an index of venous hypertension and represents the
ratio of the permeability surface area product over the EES
(Ktrans/ve). The smaller the Kep the more delayed the
enhancement.
iv. Kel (1/min)e represents thewashout or clearance of Gd out of
the ROI. A more positive Kel indicates a more rapid washout.
v. A.Kep (1/min)e initial uptake of Gd in the ROI that models the
slope but is found via ﬁtting of the entire curve by the model.Statistical analysis
We assessed the relation between perfusion parameters in BML
with WOMAC pain and night pain (dependent variable-one item
from WOMAC pain subscale). These were adjusted with their
respective muscle variables as internal control. The relation
between perfusion and WOMAC pain was assessed using a linear
regression model, assuming the normal distribution of WOMAC
pain score. Pain score at night while sleeping was categorized into
three levels from none (0 or 1), tomoderate2, tomoderate or more3,
and ordinal logistic regression model was performed to test its
relationship with BML perfusion. The proportional odds assump-
tion inherent in the ordinal logistic regression model will was
tested ﬁrst. A non-signiﬁcant test result was taken as the evidence
that this assumption was met and the odds ratios (ORs) from the
model was interpreted as the odds of being “lower” or “higher” on
the response variable across the entire range of the outcome. The
relation of BML grade to perfusion and pain at night were alsoTable II
The relation of BML grade to perfusion
Perfusion parameters Bivariable estimate effect e b coefﬁcient
BML slope/muscle slope 1.911 (4.430, 0.607)
BML A/muscle A 0.303 (1.707, 1.102)
BML Kep/muscle Kep 0.423 (1.173, 0.326)
BML Kel/muscle Kel 0.380 (0.161, 0.599)*
BML A.Kep/muscle A.Kep 2.256 (5.819, 1.306)
*P < 0.005.
Multivariable model adjusted for age, BMI and gender.assessed, with linear regression for the former and ordinal logistic
regression for the latter, respectively.
For each model, the unadjusted and adjusted estimated values,
along with 95% conﬁdence interval (95% CI) and P-values were
reported. Analyses were conducted with SAS v9.2, SAS Institute,
Cary, NC. P < 0.05 with two-sided test was considered statistically
signiﬁcant.
Results
The characteristics of the participants in this study are shown in
Table I. A total of 37 subjects (21 females and 16males) with a mean
age of 64.9 years and a mean BMI in the overweight category of
28.9 kg/m2. The mean WOMAC pain score was 10.2 (0e20 scale)
which indicates a study population with moderate pain severity.
The majority (75.6%) had BMLs that were classiﬁed grades 1 and 2
according to lesion size. The median no. of tibial BMLs was 2 (range
1e5). The largest BML (maximum grade) was selected for DCE
analysis.
Table II shows the relationship between BML grade and the ﬁve
perfusion parameters. There was a signiﬁcant correlation in the
bivariable and multivariable analyses between BML Kel and BML
grade, after adjusting for age, gender and BMI. There was no
signiﬁcant association between BML grade and the other four
perfusion parameters. Figure 1 reﬂects the negative relationship
between BML Kel and BML grades (P ¼ 0.002) consistent with
a hypothesis of venous obstruction. Examples of the DCE MRI
acquisition and measurement are included as Fig. 2.
The relationship between BML perfusion and WOMAC pain is
presented in Table III. Bivariable analysis showed the signiﬁcant
positive relationships between BML A, BML A.Kep andWOMAC pain
(for BML A, P ¼ 0.038 (95% CI: 0.021e0.690); for BML A.Kep,
P ¼ 0.024 (95% CI: 0.020e0.276)). However, when adjusting the
effects of BML grade, age, gender and BMI, neither of them
remained signiﬁcant (for BML A, P ¼ 0.231 (95% CI: 0.138 to
0.551); for BML A Kep, P ¼ 0.088 (95% CI: 0.018 to 0.246)).(95% CI) Multivariable estimate effect e b coefﬁcient (95% CI)
1.794 (4.127, 0.540)
0.331 (1.634, 1.011)
0.404 (1.172, 0.364)
0.361 (0.143, 0.579)*
2.288 (5.656, 1.079)
Fig. 2. Representative images of DCE MRI acquisition. Notice that there is more rapid
washout or clearance of the Gd compared to muscle in the lower grade 1 BML’s. This
implies more normal elimination and proper venous outﬂow. Our ﬁndings indicated
that the larger BMLs (see grade 3 lesion) had a more negative Kel (more delayed
clearance) indicating more delayed venous outﬂow. Arrow indicates location of BML.
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at night (Table IV). A statistically non-signiﬁcant test means that the
proportional odds assumption of each ordinal logistic regression
was not violated (P > 0.05). The signiﬁcant association was tested
between BML Kep and pain at night while sleeping after controlling
for the effects of BML grade, age, gender and BMI. With BML Kep
increase, patients are more likely to have moderate pain at sleep
(OR ¼ 1.65, 95% CI: 1.03e2.65, P ¼ 0.039).
Finally, Fig. 3 depicts the relationship between pain at night
with BML grade (Fisher’s exact test P ¼ 0.715). It is noteworthy thatTable III
Relation between BML perfusion and pain
Perfusion parameters Model 1
Estimate effect (95% CI)
BML slope/muscle slope 0.124 (0.064, 0.312)
BML A/muscle A 0.355 (0.021, 0.690)
BML Kep/muscle Kep 0.168 (0.487, 0.823)
BML Kel/muscle Kel 0.550 (2.507, 1.408)
BML A.Kep/muscle A.Kep 0.148 (0.020, 0.276)
Model 1. Relation between WOMAC Pain scores and BML perfusion and muscle.
Model 2. Relation between WOMAC Pain scores with BML perfusion and muscle, adjust
Italics indicates P < 0.05.the vastmajority of participants (90%) in the BML grade 3 group had
none or mild pain at sleep compared to 79% and 69% in the BML
grades 1 and 2 groups respectively, suggesting that larger BMLs do
not result in more pain at night, although this difference is not
signiﬁcant. The patients with BML grade ¼ 3 are less likely to have
pain at night than those with BML grade 1 or 2 (compared to grade
1: OR ¼ 0.38, 95% CI: 0.07e2.01; compared to grade 2: OR ¼ 0.44,
95% CI: 0.08e2.58).
Discussion
The relationship of bone marrow perfusion to pain in knee OA
remains an enigma. Data in the OA literature regarding this have
also proved conﬂicting. Whilst some studies, albeit small ones do
not suggest any association between BMLs to pain22, the balance of
data however, supports a strong relationship between BMLs and
pain in OA5. Their presence can potentially alter ﬂuid dynamics and
perfusion in subchondral bone which can result in intraosseous
hypertension, bone necrosis and cartilage breakdown23. Whilst
previous studies in the OA literature support a link between BMLs
and knee pain, few have evaluated bone perfusion in relation to
knee pain in OA. Our study used DCE MRI with Gd-DTPA to extract
kinetic information on bone perfusion in association with these
lesions. In this population of participants with symptomatic knee
OA, our study yielded three main ﬁndings in relation to bone
perfusion and pain.
 There was a correlation with BML size and rate of contrast
elimination (Kel).
Contrast elimination reﬂects venous stasis and intraosseous
hypertension as a consequence of venous outﬂow obstruction.
The ﬁnding of a signiﬁcant association with BML size and the
rate of contrast elimination is consistent with previous work on
perfusion parameters that point to outﬂow obstruction as the
primary change in kinetic parameters24. These authors
demonstrated that perfusion out of the ROI was signiﬁcantly
lower in BMLs when compared with normal bone. It would
have been expected that the rate of perfusion between extra-
cellular space and plasma (Kep) would also increase with BML
size due to intraosseous hypertension.
Some of the vascular changes associated with BMLs have
been recognized as replacement of the normal subchondral
marrow with ﬁbrovascular granulation tissue. Saadat et al.25
assessed patients with advanced knee OA and reported that
there was a correlation of BMLs with ﬁbrovascular tissue
ingrowth of bone as a result of angiogenesis which leads to new
increased blood ﬂow to the area. This ﬁbrovascular tissue is
continuous with the vascular channels which invade the
articular cartilage in BMLs and are associated with knee pain26.
The contribution of angiogenesis to pain enables the innerva-
tion of tissues and may synergize with inﬂammation to exac-
erbate pain27.Model 2
P-value Estimate effect (95% CI) P-value
0.190 0.112 (0.084, 0.308) 0.253
0.038 0.207 (0.138, 0.551) 0.231
0.606 0.163 (0.442, 0.768) 0.588
0.572 0.524 (2.657, 1.608) 0.620
0.024 0.114 (0.018, 0.246) 0.088
ed for BML grade, age, gender and BMI.
Table IV
Relation between BML perfusion and pain at sleeping
Perfusion parameters Model 1 Model 2
OR (95% CI) Proportional odds assumption P-value* OR (95% CI) Proportional odds assumption P-value*
BML slope/muscle slope 1.10 (0.99, 1.23) 0.713 1.13 (0.99, 1.29) 0.989
BML A/muscle A 1.08 (0.90, 1.30) 0.832 0.97 (0.79, 1.20) 0.976
BML Kep/muscle Kep 1.52 (0.99, 2.34) 0.222 1.65 (1.03, 2.65) 0.887
BML Kel/muscle Kel 0.73 (0.27, 2.01) 0.583 1.00 (0.28, 3.62) 0.965
BML A.Kep/muscle A.Kep 1.06 (0.99, 1.14) 0.669 1.04 (0.96, 1.13) 0.986
Model 1. Relation between WOMAC Pain with sleeping scores and BML perfusion and muscle.
Model 2. Relation between WOMAC Pain with sleeping scores with BML perfusion and muscle, also adjusts for BML grade, age, gender and BMI.
Italics indicates P < 0.05.
* Score test for proportional odds assumption.
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important covariates.
The failure to ﬁnd an association of bone perfusion with pain
is of interest and suggests that perfusion of BMLs does not
contribute to their pain genesis. Other studies also allude
that knee pain stems from many other causes and even
though BMLs are associated with pain in OA, this association
with pain is signiﬁcant only in the presence of other
abnormal articular changes. Torres et al.28 agreed that BMLs
alone were not sufﬁcient to account for pain and its contri-
bution to pain severity appeared to require the presence of
other modiﬁcations such as capsular distention and bone
attrition. Attrition of bone is a more common ﬁnding in
peoplewith knee pain and OA than thosewith OAwithout knee
pain29. By the time a patient experiences pain and has evidence
of OA onMRI, many other pathologic features such as synovitis,
synovial effusions and cysts coexist whichmakes it challenging
to identify the single feature that causes the most pain30.
There have also been studies that did not ﬁnd any associa-
tion between BML size and pain in OA31,32. An attempt to
reconcile these data could be that the presence of BML and
altered perfusion may only signal an element of susceptibility
for the induction of pain whose expression still required addi-
tional structural abnormalities within the knee33. Moreover,
BMLs grades 1 and 2 had small volumes compared to the total
joint volume and may not contribute to the overall knee pain.
We did ﬁnd a positive association of BML Kep and pain at night
suggesting a potential relationship between the permeability
of the BMLs and nocturnal pain. The underlying mechanism for
this relationship is unclear andwould beworth investigating in
future studies to see if this can be replicated.Fig. 3. Relationship between pain at night while sleeping and BML grade. Trend to inverse correlation between pain at night and BML
grade
Larger BMLs have been shown to be associated with higher
grades of cartilage defects8 and one would again expect
increasing BML size to be associated with greater pain scores.
This was therefore a result that was contrary to what we
hypothesized.
There are two possible explanations for this unexpected ﬁnding.
Firstly, it is not clear if BMLs exhibit a homogenous expression in
all patients. Previous histopathological studies have demon-
strated that the BMLs themselves consist of a mixed pathology
including granulation, diffuse necrosis, ﬁbrinoid deposition and
blood vessel wall hyperplasia18. In addition, histologically it has
also been reported that only 4% of BMLs contained edema and
that they consisted of other irregularities such as marrow
ﬁbrosis and trabecular remodeling17,34. Pain initiation from BML
abnormalities emanate from the fact that necrotic cells release
neuromediators33. It will therefore also be of interest to ascer-
tain the degree and amount of necrosis within these BMLs to
determine if size does also correlate with necrosis. In light of
these, the BMLs in our study participants may not have been
homogeneously edematous and that other characteristics
within the whole knee joint may also be responsible for the
induction of pain. Different MRI sequences might yield different
results and the results presented have to be interpreted in light
of sequence used and to date sequence comparisons aremissing
for DCE MRI and BMLs.
There are several limitations of the study that require
mentioning. Firstly, we evaluated the association of BMLs and
pain of the entire knee. Differences in the compartmental BMLs
and their relation to pain at their respective anatomical sites
were therefore not examined. The second limitation was that
we did not take into account that in addition to BMLs and
altered perfusion, there are multiple joint structures within the
knee such as subchondral bone cysts and synovitis that could
also have contributed to knee pain. Future research into this
area could include patient subgroups with other subchondral
bone pathology that may shed more light on their relationship
with bone perfusion and pain in OA. Another limitationwas the
lack of concomitant information regarding OA treatments the
participants may currently be receiving or have received
previously such as chondroitin, hyaluronate and physiotherapy
which could have affected the size of BML, pain, ﬂuid dynamics
and bone perfusion. In future studies it would also be impor-
tant to have histologic correlation and a broader sample rep-
resenting different stages of disease severity and not just those
with end-stage disease. It is possible that the central region on
which the DCE MRI was assessed may have different angio-
genic activity and contrast uptake to the rim of enhancement in
the periphery seen on the FS sequence. Different MRI
sequences might yield different results, the results presented
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to date sequence comparisons are missing for DCE MRI and
BMLs. Future studies should extend our ﬁndings to include the
whole BML and other regions of the joint including the femur.
To conclude, OA is a dynamic disease process with inter-
connecting symptoms and structural changes. Even though
there is increasing evidence that BMLs play an important part in
the pathogenesis of knee OA, BMLs are formed from various
causes, all of which may be interacting and complex and
comprise of biomechanical, genetic and inﬂammatory compo-
nents, of which bone perfusion is only one aspect. The mixed
results in our study imply that the pathological and functional
signiﬁcance of tibial BMLs in relation to pain is still a matter of
debate. Ascertaining which structures in the knee with OA are
associated with pain will aid our understanding of the patho-
physiology of OA and lead to the development of more effective
therapeutic options to delay disease progression.Author contributions
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